Hyblate Medical

Hybrid Catheter to Treat Atrial Fibrillation

Health Tech & Life Sciences

Non Active, Feb 2023 ceased to operate

Pre-Seed Founded 2018

Total raised

—

Last: Pre-Seed 2018-08

Stage

Pre-Seed

Founded

2018

Headcount

1-10

—

Sector

Health Tech & Life Sciences

About

Hyblate Medical developed the Hyblate catheter to treat atrial fibrillation (irregular heartbeat). Hyblate offers a safe and effective treatment for atrial fibrillation by combining the advantages of two current ablation methods into a hybrid catheter with effective control mechanisms.

Funding history · 1 round · — total

2018-08

Pre-Seed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Name	Hyblate Medical
Slug	hyblate-medical
Type	Israeli Startup
Founded	2018
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Seed
Public stage	Pre-Seed
Total raised (USD)	0
Last round	Pre-Seed (2018-08)
Israeli Companies Registrar	515865228

Name	Role	LinkedIn
Rami Shachar
Liron Tayeb
Mahmoud Suleiman
Lior Gepstein

Hyblate Medical

About

Funding history · 1 round · — total

Sectors & technology

Tags

Hyblate Medical — Full Company Profile (machine-readable)

About

Facts

Funding rounds (1)

Team (4)

About

Funding history · 1 round · — total

Sectors & technology

Tags

Generate Slim Page